EA
ELV icon

Emerald Advisers’s Elevance Health ELV Stock Holding History

Emerald Advisers’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-1,773
Closed -$191K – 368
2014
Q2 		$191K Sell
1,773
-578
-25% -$59.6K 0.01% 356
2014
Q1 		$234K Sell
2,351
-187
-7% -$16.9K 0.01% 333
2013
Q4 		$234K Hold
2,538
– – 0.01% 324
2013
Q3 		$212K Sell
2,538
-203
-7% -$17.4K 0.01% 331
2013
Q2 		$224K Buy
+2,741
New +$205K 0.01% 321

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Emerald Advisers's ELV Position: Q3 2014 in Review

Emerald Advisers sold out of Elevance Health (ELV) in Q3 2014, closing a stake of 1,773 shares — an estimated $191K sold.

Emerald Advisers first reported a position in ELV in Q2 2013 and held it in 5 quarters. The position peaked at $234K in Q1 2014. 708 funds tracked by Wall St. Rank hold ELV as of Q3 2014.

  • Emerald Advisers reported no remaining Elevance Health position as of Q3 2014 after selling out during the quarter.
  • Emerald Advisers sold 1,773 Elevance Health shares in Q3 2014, an estimated $191K.
  • Emerald Advisers first reported a position in Elevance Health in Q2 2013 and held it in 5 quarters.
  • Emerald Advisers's Elevance Health position peaked at $234K in Q1 2014.
  • 708 funds tracked by Wall St. Rank held Elevance Health as of Q3 2014.

Based on Emerald Advisers's 13F filing for Q3 2014, filed 28 Oct 2014.